Our top pick for
IBEX Limited is a software-application business based in the US. IBEX shares (IBEX) are listed on the NASDAQ and all prices are listed in US Dollars.
|Latest market close||$17.59|
|52-week range||$14.04 - $25.50|
|50-day moving average||$17.64|
|200-day moving average||$20.22|
|Wall St. target price||$24.60|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.15|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||3.47%|
|1 month (2021-09-22)||-3.30%|
|3 months (2021-07-22)||-21.12%|
|6 months (2021-04-22)||-23.59%|
|1 year (2020-10-22)||12.97%|
|2 years (2019-10-18)||N/A|
|3 years (2018-10-18)||N/A|
|5 years (2016-10-18)||N/A|
Valuing IBEX stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of IBEX's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
IBEX's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 113x. In other words, IBEX shares trade at around 113x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
IBEX's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $42.7 million.
The EBITDA is a measure of a IBEX's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$443.7 million|
|Operating margin TTM||7.25%|
|Gross profit TTM||$133.1 million|
|Return on assets TTM||8.56%|
|Return on equity TTM||5.88%|
|Market capitalisation||$312.6 million|
TTM: trailing 12 months
There are currently 52,530 IBEX shares held short by investors – that's known as IBEX's "short interest". This figure is 5.2% up from 49,933 last month.
There are a few different ways that this level of interest in shorting IBEX shares can be evaluated.
IBEX's "short interest ratio" (SIR) is the quantity of IBEX shares currently shorted divided by the average quantity of IBEX shares traded daily (recently around 32030.487804878). IBEX's SIR currently stands at 1.64. In other words for every 100,000 IBEX shares traded daily on the market, roughly 1640 shares are currently held short.
However IBEX's short interest can also be evaluated against the total number of IBEX shares, or, against the total number of tradable IBEX shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case IBEX's short interest could be expressed as 0% of the outstanding shares (for every 100,000 IBEX shares in existence, roughly 0 shares are currently held short) or 0.0104% of the tradable shares (for every 100,000 tradable IBEX shares, roughly 10 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against IBEX.
Find out more about how you can short IBEX stock.
We're not expecting IBEX to pay a dividend over the next 12 months.
IBEX Limited provides end-to-end technology-enabled customer lifecycle experience solutions in the United States and internationally. The company provides ibex Connect, a customer engagement solution that comprises customer service, technical support, revenue generation, and other value-added outsourced back-office services through the CX model, which integrates voice, email, chat, SMS, social media, and other communication applications; ibex Digital, a customer acquisition solution that includes digital marketing, e-commerce technology, and platform solutions; and ibex CX, a customer experience solution, which provides a suite of proprietary software tools to measure, monitor, and manage its clients' customer experience. As of October 1, 2021, the company operated 33 customer engagement and three customer acquisition delivery centers. It serves banking and financial services, delivery and logistics, health tech and wellness, high tech, retail and e-commerce, streaming and entertainment, travel and hospitality, and utility industries. The company was formerly known as IBEX Holdings Limited and changed its name to IBEX Limited in September 2019. The company was incorporated in 2017 and is headquartered in Washington, District of Columbia. IBEX Limited is a subsidiary of The Resource Group International Limited.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.